PASITHEA THERAPEUTICS CORP. Increase Decrease In Operating Lease Liability
PASITHEA THERAPEUTICS CORP. (KTTA) reported Increase Decrease In Operating Lease Liability of -$2.41 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-03-30
- PASITHEA THERAPEUTICS CORP. increase decrease in operating lease liability for the quarter ending 2024-12-31 was $0.00.
- PASITHEA THERAPEUTICS CORP. increase decrease in operating lease liability for the quarter ending 2024-09-30 was $0.00.
- PASITHEA THERAPEUTICS CORP. increase decrease in operating lease liability for the quarter ending 2024-06-30 was -$963.00.
- PASITHEA THERAPEUTICS CORP. increase decrease in operating lease liability for the quarter ending 2024-03-31 was -$1.45K.
- PASITHEA THERAPEUTICS CORP. increase decrease in operating lease liability for fiscal 2024 was -$2.41K.
- PASITHEA THERAPEUTICS CORP. increase decrease in operating lease liability for fiscal 2023 was -$1.55K, a 100.28% decline from fiscal 2022.
- PASITHEA THERAPEUTICS CORP. increase decrease in operating lease liability for fiscal 2022 was $543.96K, a 23.44% increase from fiscal 2021.
- PASITHEA THERAPEUTICS CORP. increase decrease in operating lease liability for fiscal 2021 was $440.68K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month | Increase Decrease In Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | -$963.00 derived: sum of 3 quarters · filed 2026-03-30 | -$2.41K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$963.00 derived: sum of 2 quarters · filed 2025-11-13 | -$2.41K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$963.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$2.41K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | -$1.45K 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | -$1.55K 10-K · filed 2025-03-24 | ||||
| 2022-12-31 | $561.52K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $512.61K derived: sum of 2 quarters · filed 2024-03-29 | $543.96K 10-K · filed 2024-03-29 | $831.64K 10-K · filed 2023-03-30 | |
| 2022-09-30 | -$48.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$17.56K 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | $31.35K 10-Q · filed 2023-08-11 | ||||
| 2021-12-31 | $440.68K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |